P3781
Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle TrackingStress CT Perfusion in Patients With Chest PainStress Testing and Cardiac Magnetic ResonanceA Study of the Safety and Tolerance of Regadenoson in Subjects With Renal ImpairmentA Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary DiseaseEffects of Body Mass Index on the Hyperemic Response to RegadenosonStress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast CancerA Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCIWhole-Heart Myocardial Blood Flow Quantification Using MRIRegadenoson Real Time Perfusion Imaging Trial-OptisonDiagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery DiseaseAttenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients With Severe Kidney Disease Undergoing Myocardial Perfusion ImagingA Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)Arm Exercise Versus Pharmacologic Stress Testing for Clinical OutcomeThe MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPI
P4844
Q61894398-89FAFA2D-94CF-46F0-B7FE-2439D4F7EC7EQ61975396-8E068C74-5077-44D3-A209-7AC7170744B8Q61980552-7668ADD9-7E09-4E2E-A6F5-21388A95DD4AQ61981222-8B19B4F6-2D30-414F-8228-3179A3F3A526Q61981305-270C3D82-AD74-45D2-8F5E-C27BD1F68C08Q61981570-85BC4AF5-4619-45BC-BDB1-E8511E6FF0A7Q62823307-BB7FD192-11BF-47CD-92C6-6959EDCC2557Q63011271-A7E8CAEF-DADD-42A4-8248-79DFAE271160Q63229624-A0FF489D-A63A-4E20-B8CA-D9959AB4DBDAQ63321135-159C3E60-58C6-4075-8E10-CBC91C805E8EQ63321586-FBEDFB7D-1F88-4EE5-BC40-8BDC737F0F01Q63335992-9EC4F14A-93BA-4B76-A473-C1154C78F8F8Q63336341-FDE9288F-A88F-4D49-BBAF-C448FA9C1762Q63400915-CC718719-BEE9-4706-8137-1F7DB0F6296DQ89154188-62992E83-801A-4B4F-9A04-DF2C11F74AB8
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Regadenoson
@vi
Regadenozon
@sh
Regadenozon
@sr
regadenoson
@ca
regadenoson
@en
regadenoson
@es
レガデノソン
@ja
type
label
Regadenoson
@vi
Regadenozon
@sh
Regadenozon
@sr
regadenoson
@ca
regadenoson
@en
regadenoson
@es
レガデノソン
@ja
altLabel
ATC kod C01EB21
@sr
ATCvet kod QC01EB21
@sr
C15H18N8O5
@sr
CVT-3146
@en
CVT-3146
@sr
Leksisken
@sr
Lexiscan
@sr
Lexiscan®
@en
Rapiscan
@sr
Rapiscan®
@en
prefLabel
Regadenoson
@vi
Regadenozon
@sh
Regadenozon
@sr
regadenoson
@ca
regadenoson
@en
regadenoson
@es
レガデノソン
@ja
P129
P592
P6366
P661
P662
P665
P683
P2017
CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O
P2067
P2115
N0000176153
P2275
Regadenoson
@en
P231
313348-27-5
P232
P233
CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3C4C(C(C(O4)CO)O)O